Vestibular tissue changes following administration of intravaginal prasterone: a vulvoscopic open-label pilot study in menopausal women with dyspareunia

BACKGROUND: Prasterone, an intravaginal dyspareunia treatment in menopausal women, improves vaginal health through intracellular conversion of dehydroepiandrosterone into androgens and estrogens. Phase 3 trials for prasterone showed significant improvement in vaginal tissue health and reduction of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein, Sue W, Goldstein, Irwin, Kim, Noel N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281961/
https://www.ncbi.nlm.nih.gov/pubmed/37351544
http://dx.doi.org/10.1093/sexmed/qfad028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281961/
https://www.ncbi.nlm.nih.gov/pubmed/37351544
http://dx.doi.org/10.1093/sexmed/qfad028

Ejemplares similares